Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally

被引：6
|
作者：
Behr, Juergen [1 ]
机构：
[1] Univ Hosp LMU, Dept Med 5, German Ctr Lung Res DZL, Munich, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 02期
关键词：
SILDENAFIL; FIBROSIS; ILOPROST;
D O I：
10.1164/rccm.202110-2444ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：144 / 146
页数：4
相关论文
共 50 条
  • [11] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Genecand, Leon
    Lador, Frederic
    Montani, David
    Perneger, Thomas
    [J]. CHEST, 2024, 165 (05) : e161 - e161
  • [12] Inhaled treprostinil for pulmonary hypertension
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (2): : 64 - 65
  • [13] Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
    West, Natalie
    Smoot, Karen
    Patzlaff, Natalie
    Miceli, Melissa
    Waxman, Aaron
    [J]. FUTURE CARDIOLOGY, 2023, 19 (05) : 229 - 239
  • [14] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Response
    Nathan, Steven D.
    Shen, Eric
    Deng, Chunqin
    [J]. CHEST, 2024, 165 (05) : e162 - e162
  • [15] Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
    Zisman, David
    Dubrock, Hilary
    King, Christopher
    Weaver, Sheila
    Nathan, Steven
    Rahaghi, Franck
    Kim, Hyoshin
    Rao, Youlan
    Shen, Eric
    Waxman, Aaron
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [16] DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
    Waxman, Aaron
    Nathan, Steven
    Fisher, Micah
    Ford, H. James
    Gagermeier, James
    Parambil, Joseph
    Raina, Amresh
    Zwicke, Dianne
    Gerke, Alicia
    Shen, Eric
    Lee, Dasom
    Rao, Youlan
    Tapson, Victor
    [J]. CHEST, 2021, 160 (04) : 2279A - 2280A
  • [17] Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease Is All Clear?
    Carbone, Roberto G.
    Monselise, Assaf
    Puppo, Francesco
    [J]. CHEST, 2023, 164 (01) : e21 - e21
  • [18] Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
    Piccari, Lucilla
    Wort, Stephen John
    [J]. THORAX, 2024, 79 (04) : 295 - 296
  • [19] Inhaled treprostinil sodium for pulmonary hypertension
    Gupta, Vedant
    Krasuski, Richard A.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (03): : 283 - 291
  • [20] Inhaled treprostinil and pulmonary arterial hypertension
    Nadler, Samuel T.
    Edelman, Jeffrey D.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1115 - 1124
12345